-5%
S-31 10mg
Original price was: $62.00.$59.00Current price is: $59.00.Legal Notice: Research peptides are sold exclusively to licensed researchers and authorized institutions for laboratory use only. Not for human consumption, therapeutic use, or clinical applications. Not evaluated by the FDA. Users must verify compliance with applicable regulations and assume full responsibility for handling and outcomes. All materials are provided “as-is” without warranty. Product names are trademarks of their respective owners.
Note: This research product has been renamed to “S-31 (Elamipretide)” for regulatory compliance purposes. The compound formulation, research protocols, and all specifications remain completely unchanged. Only the display name has been updated.
S-31 (Elamipretide) is a synthetic tetrapeptide belonging to the Szeto-Schiller family of mitochondria-targeting peptides, designed to selectively target and bind to cardiolipin, a phospholipid in the inner mitochondrial membrane where it stabilizes mitochondrial structure and reduces oxidative damage.
Current Batch: A2S311125 | Cap/Crimp: Pink / Silver —
Now Shipping!
Now Shipping!
| STRENGTH | LAST TEST | AVG MASS | AVG PURITY |
|---|---|---|---|
| 10 mg | 21 Nov 2025 2 tests conducted | 10.26 mg (+2.55%) 2 vials tested | 99.76% (2 vials tested) |
-25%
SLU-PP-332 5mg Lyophilized
Original price was: $73.00.$54.50Current price is: $54.50.Legal Notice: Research peptides are sold exclusively to licensed researchers and authorized institutions for laboratory use only. Not for human consumption, therapeutic use, or clinical applications. Not evaluated by the FDA. Users must verify compliance with applicable regulations and assume full responsibility for handling and outcomes. All materials are provided “as-is” without warranty. Product names are trademarks of their respective owners.
SLU-PP-332 is a selective small molecule inhibitor that targets the CB1 cannabinoid receptor with peripheral selectivity, designed to avoid crossing the blood-brain barrier. At the cellular level, this compound blocks CB1 receptor signaling pathways in peripheral tissues while minimally affecting central nervous system CB1 receptors.
Current Batch: A2SLU50925 | Cap/Crimp: Yellow / Silver — Now Shipping!
| STRENGTH | LAST TEST | AVG MASS | AVG PURITY |
|---|---|---|---|
| 5 mg | 23 Oct 2025 3 tests conducted | 5.51 mg (+10.20%) 3 vials tested | 99.30% (3 vials tested) |
